What are the differential diagnoses for progressive bleeding from a below‑knee amputation (BKA) stump in a patient with an estimated glomerular filtration rate (eGFR) of 10 mL/min/1.73 m² and a normal platelet count?

Differential Diagnoses for Progressive BKA Stump Bleeding in Severe CKD

In a post-BKA patient with eGFR of 10 mL/min/1.73 m² and normal platelet count, progressive stump bleeding is most likely due to uremic platelet dysfunction, followed by surgical/anatomical causes, with coagulopathy from other mechanisms being less common but critical to exclude.

Primary Differential Diagnoses

1. Uremic Platelet Dysfunction (Most Likely)

With an eGFR of 10 mL/min/1.73 m², this patient has stage 5 CKD 1, 2, 3. Despite normal platelet count, qualitative platelet dysfunction is the hallmark bleeding disorder in advanced CKD. Recent evidence demonstrates that patients with eGFR <30 mL/min/1.73 m² have significantly altered coagulation profiles 4. The study by 4 specifically showed that CKD patients with spontaneous major bleeding had more hypocoagulable parameters on global coagulation assays, with bleeding rates of 3.0/100 person-years in advanced CKD.

Key mechanism: Uremic toxins impair platelet adhesion and aggregation through:

• Impaired von Willebrand factor-platelet interaction
• Reduced platelet glycoprotein IIb/IIIa expression
• Accumulation of uremic toxins (guanidinosuccinic acid, phenolic acids)
• Anemia-related decreased platelet margination

2. Surgical/Anatomical Causes

• Inadequate hemostasis during surgery: Unligated vessels, particularly in the posterior flap
• Stump ischemia with tissue breakdown: Compromised arterial inflow leading to poor wound healing and vessel exposure 5, 6
• Infection with vessel erosion: Particularly relevant if uncontrolled infection was present
• Hematoma formation with delayed rupture

The evidence shows that 22.6% of BKA patients require revision surgery 6, with vascular patency being critical. Patent profunda femoris artery was significantly associated with healing (73% vs 35% in failed cases, P<0.0001) 6.

3. Medication-Related Coagulopathy

• Antiplatelet agents: Even with normal platelet count, aspirin/clopidogrel cause irreversible platelet dysfunction
• Anticoagulants: Warfarin, DOACs (though dosing should be adjusted for eGFR 10) 7
• NSAIDs: Commonly used for pain, exacerbate uremic platelet dysfunction
• Antibiotics: Certain beta-lactams can impair platelet function

4. Acquired Coagulation Factor Deficiencies

• Vitamin K deficiency: From poor nutrition, antibiotics, or malabsorption
• Liver dysfunction: Check for concurrent hepatic impairment
• Dilutional coagulopathy: If significant fluid resuscitation occurred
• Factor XIII deficiency: Can cause delayed bleeding despite normal PT/PTT

5. Vascular/Hemodynamic Factors

• Hypertension: Uncontrolled BP causing mechanical disruption of healing vessels 8
• Volume overload: Common in eGFR 10, increases venous pressure and capillary leak
• Arterial insufficiency: Diseased vessels more prone to bleeding 9, 6

6. Less Common but Important

• Acquired von Willebrand syndrome: Can occur in CKD
• Heparin-induced thrombocytopenia (HIT): If heparin exposure occurred, though platelet count is normal
• Occult malignancy-related coagulopathy
• Sepsis-induced coagulopathy: Early DIC without thrombocytopenia yet

Critical Diagnostic Workup

Immediate laboratory assessment:

• Coagulation studies: PT/INR, aPTT, fibrinogen
• Complete blood count: Confirm platelet count, assess for anemia severity
• Bleeding time or PFA-100: Directly assess platelet function (though bleeding time is falling out of favor)
• Uremia markers: BUN, creatinine (already known to be elevated)
• Medication review: Document all anticoagulants, antiplatelets, NSAIDs

Advanced testing if initial workup unrevealing:

• Global coagulation assays: Thromboelastography (TEG), calibrated automated thrombogram 4
• von Willebrand factor antigen and activity
• Factor XIII level
• Mixing studies if prolonged PT/aPTT

Anatomical assessment:

• Direct stump examination: Look for specific bleeding source, hematoma, infection
• Vascular imaging: Doppler ultrasound or angiography to assess arterial patency 6
• Wound culture: If infection suspected

Clinical Pitfalls to Avoid

1. Assuming normal platelet count excludes bleeding disorder: Qualitative platelet dysfunction is the primary issue in CKD, not quantitative 4

2. Overlooking medication contributions: Even "held" anticoagulants may have prolonged effects with eGFR 10 due to reduced clearance 7

3. Missing surgical source: Don't attribute all bleeding to uremia without direct visualization of the stump

4. Inadequate BP control: Hypertension significantly worsens bleeding risk and should be optimized 8

5. Ignoring anemia: Severe anemia (<7-8 g/dL) itself impairs hemostasis by reducing platelet margination

Management Implications

The differential diagnosis directly informs treatment:

• If uremic platelet dysfunction: DDAVP (desmopressin), cryoprecipitate, conjugated estrogens, or dialysis
• If surgical: Urgent surgical re-exploration and hemostasis
• If medication-related: Hold offending agents, consider reversal agents
• If factor deficiency: Replace specific factors or give FFP/vitamin K
• If vascular: May require revascularization before stump can heal 5, 6

The eGFR of 10 mL/min/1.73 m² places this patient at extremely high risk for both bleeding and thrombotic complications 10, 7, requiring careful balance of hemostatic interventions.